Skip to content

Clinical trials

Phase 2 Cytomegalovirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytomegalovirus Infections Phase: Phase 2 Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20081
20092
20101
20121
20131
20144
20154
20161
20171
20184
20194
20203
20214
20222
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Unknown status6
Recruiting4
Active, not recruiting4
Terminated3
Not yet recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)10
ModernaTX, Inc.4
City of Hope Medical Center2
Memorial Sloan Kettering Cancer Center2
National Heart, Lung, and Blood Institute (NHLBI)2
University Hospital, Bordeaux2
Albert Park1
Amivas Inc.1
Amy C. Sherman, MD1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytomegalovirus Infections55
HIV Infections8
Acquired Immunodeficiency Syndrome7
Retinitis6
Cytomegalovirus Retinitis5
AIDS-Related Opportunistic Infections4
DNA Virus Infections4
Multiple Acyl Coenzyme A Dehydrogenase Deficiency4
Virus Diseases4
Hematologic Neoplasms3

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.